Prognostic impact of coronary lesions and its revascularization in a 5-year follow-up after the TAVI procedure
- PMID: 37471716
- DOI: 10.1002/ccd.30767
Prognostic impact of coronary lesions and its revascularization in a 5-year follow-up after the TAVI procedure
Abstract
Background: Coronary artery disease (CAD) is a common finding in patients undergoing transcatheter aortic valve implantation (TAVI). However, its prognostic significance and its management remains controversial.
Aims: This study sought to determine whether the presence of CAD, its complexity, and angiography-guided percutaneous coronary intervention (PCI) are associated with outcomes after TAVI.
Methods: All patients undergoing TAVI at a tertiary referral center between 2008 and 2018 were included in a prospective observational study. Baseline SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score (SS) and a residual SS after PCI were calculated. The endpoints on the 5 year follow-up were all-cause mortality and a composite of mayor cardiovascular adverse events (MACE).
Results: In 379 patients, the presence of CAD and its complexity were not significantly associated with worse 5-year survival after TAVI, with a mortality for SS0 of 45%; for SS 1-22 of 36.5% (HR 0.77; 95% CI 0.53-1.11, p = 0.15) and for SS > 22 of 42.1% (HR 1.24; 95% CI 0.59-2.63, p = 0.57). Regarding the combined event of MACE, there were also no statistically significant differences between patients with CAD and without CAD (56.8% in patients without CAD and 54.9% in patients with CAD; HR 1.06; 95% CI 0.79-1.43, p = 0.7). Angiography-guided PCI or completeness of revascularization was not associated with different outcomes.
Conclusions: In the present analysis, neither the presence nor the extent of CAD, nor the degree of revascularization, was associated with a prognostic impact in patients undergoing TAVI at 5-year follow-up.
Keywords: aortic valve disease; coronary artery disease; percutaneous intervention.
© 2023 Wiley Periodicals LLC.
References
REFERENCES
-
- Faroux L, Guimaraes L, Wintzer-Wehekind J, et al. Coronary artery disease and transcatheter aortic valve replacement. JACC. 2019;74(3):362-372. doi:10.1016/j.jacc.2019.06.012
-
- Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Revista Española de Cardiología. 2022;75(6):524. doi:10.1016/j.rec.2022.05.006
-
- Tarantini G, Tang G, Fovino LN (2023). Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery.
-
- Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial Infarction(2018). Circulation. 2018;138(20):e618-e651. doi:10.1161/CIR.0000000000000617
-
- Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
